StockNews.AI
OPCH
StockNews.AI
112 days

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

1. OPCH's Q1 2025 net revenue rose 16.3% year-over-year. 2. Adjusted EBITDA for Q1 2025 increased by 13.7% to $111.8 million. 3. Net income grew to $46.7 million, reflecting a strong quarterly performance. 4. Company's stock repurchase reached $100 million in Q1 2025. 5. Updated revenue guidance for 2025 is between $5.4B and $5.6B.

Earnings
-4.52%Current Return
VS
+0.01%S&P 500
$32.9704/29 07:08 AM EDTEvent Start
$31.4804/30 01:39 PM EDTLatest Updated
15m saved
Insight
Article

FAQ

Why Bullish?

Strong revenue growth and profit improvements signal positive market sentiment, historically leading to higher stock prices.

How important is it?

Financial results significantly affect investor sentiment and stock price dynamics; strong performance often correlates with increased buying interest.

Why Short Term?

Immediate financial performance enhancements often affect stock movement shortly after release.

Related Companies

CNCAMGNHUM
April 29, 2025 07:00 ET  | Source: Option Care Health, Inc. BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted earnings per share of $0.28, up 7.7% compared to diluted earnings per share of $0.26 in the first quarter of 2024Adjusted net income of $67.1 million, compared to adjusted net income of $61.6 million in the first quarter of 2024 and adjusted diluted earnings per share of $0.40, up 14.3% compared to adjusted diluted earnings per share of $0.35 in the first quarter of 2024Adjusted EBITDA of $111.8 million, up 13.7% compared to $98.3 million in the first quarter of 2024Cash used in operating activities of $7.2 million, compared to cash used in operating activities of $68.8 million in the first quarter of 2024Repurchased approximately $100.0 million of stock in the first quarter of 2025 John C. Rademacher, Chief Executive Officer, commented, “The Option Care Health team’s execution in a dynamic environment produced another great quarter of results. Overall, we expect 2025 to be a productive year as we continue to invest for future growth to further expand patient access to quality care.” Updated Full Year 2025 Financial Guidance For the full year 2025, Option Care Health now expects to generate: Net revenue of $5.4 billion to $5.6 billionAdjusted diluted earnings per share of $1.61 to $1.70Adjusted EBITDA of $455 million to $470 millionCash flow from operations of at least $320 millionEffective tax rate of 25% - 27%Net interest expense of approximately $55 million to $60 million Conference Call Option Care Health will host a conference call to discuss its first quarter 2025 financial results later today at 8:30 a.m. ET. The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. About Option Care Health Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com. Investor Contact Forward-Looking Statements - Safe Harbor This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws and regulations applicable to our business model; changes in market conditions and receptivity to our services and offerings; pending and future litigation; potential liability for claims not covered by insurance; and loss of relationships with managed care organizations and other non-governmental third party payers. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our periodic reports as filed with the SEC. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Note Regarding Use of Non-GAAP Financial Measures In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted earnings per share ("Adjusted EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, earnings per share, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted earnings per share represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long‑lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Health’s business operations and facilitate comparisons to the Company’s historical operating results. We have not reconciled Adjusted EBITDA or Adjusted diluted earnings per share guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each adjusted measure to the most comparable GAAP financial measure are set forth below.   Schedule 1 OPTION CARE HEALTH, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(IN THOUSANDS)(UNAUDITED)  March 31, 2025 December 31, 2024ASSETS   CURRENT ASSETS:   Cash and cash equivalents$171,372 $412,565Accounts receivable, net 476,649  409,733Inventories 369,034  388,131Prepaid expenses and other current assets 82,320  112,198Total current assets 1,099,375  1,322,627    NONCURRENT ASSETS:   Property and equipment, net 131,264  127,367Intangible assets, net 24,427  16,993Referral sources, net 312,586  284,017Goodwill 1,605,930  1,540,246Other noncurrent assets 134,931  130,493Total noncurrent assets 2,209,138  2,099,116TOTAL ASSETS$3,308,513 $3,421,743    LIABILITIES AND STOCKHOLDERS’ EQUITY   CURRENT LIABILITIES:   Accounts payable$528,848 $610,779Other current liabilities 184,816  169,367Total current liabilities 713,664  780,146    NONCURRENT LIABILITIES:   Long-term debt, net of discount, deferred financing costs and current portion 1,104,160  1,104,641Other noncurrent liabilities 139,855  132,718Total noncurrent liabilities 1,244,015  1,237,359Total liabilities 1,957,679  2,017,505    STOCKHOLDERS’ EQUITY 1,350,834  1,404,238TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$3,308,513 $3,421,743  Schedule 2 OPTION CARE HEALTH, INC.CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)  Three Months Ended March 31,  2025   2024 NET REVENUE$1,332,972  $1,146,052 COST OF REVENUE 1,069,920   907,552 GROSS PROFIT 263,052   238,500     OPERATING COSTS AND EXPENSES:   Selling, general and administrative expenses 168,118   154,742 Depreciation and amortization expense 15,746   14,728 Total operating expenses 183,864   169,470 OPERATING INCOME 79,188   69,030     OTHER INCOME (EXPENSE):   Interest expense, net (13,231)  (13,202)Other, net (2,401)  1,127 Total other expense (15,632)  (12,075)    INCOME BEFORE INCOME TAXES 63,556   56,955 INCOME TAX EXPENSE 16,814   12,164 NET INCOME$46,742  $44,791     Earnings per share, basic$0.28  $0.26 Earnings per share, diluted$0.28  $0.26     Weighted average common shares outstanding, basic 165,460   173,928 Weighted average common shares outstanding, diluted 166,804   175,624   Schedule 3 OPTION CARE HEALTH, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(IN THOUSANDS)(UNAUDITED)  Three Months Ended March 31,  2025   2024 CASH FLOWS FROM OPERATING ACTIVITIES:   Net income$46,742  $44,791 Adjustments to reconcile net income to net cash used in operations:   Depreciation and amortization expense 16,373   15,305 Other non-cash adjustments 17,642   21,097 Changes in operating assets and liabilities:   Accounts receivable, net (56,788)  (195,992)Inventories 21,790   32,056 Prepaid expenses and other current assets 28,444   4,878 Accounts payable (88,101)  59,223 Accrued compensation and employee benefits (14,458)  (49,884)Other 21,142   (258)Net cash used in operating activities (7,214)  (68,784)    CASH FLOWS FROM INVESTING ACTIVITIES:   Acquisition of property and equipment (9,371)  (5,820)Business acquisitions, net of cash acquired (117,322)  — Net cash used in investing activities (126,693)  (5,820)    CASH FLOWS FROM FINANCING ACTIVITIES:   Purchase of company stock, and related excise taxes (100,222)  (40,050)Other financing cash flows (7,064)  (9,682)Net cash used in financing activities (107,286)  (49,732)    NET DECREASE IN CASH AND CASH EQUIVALENTS (241,193)  (124,336)Cash and cash equivalents - beginning of the period 412,565   343,849 CASH AND CASH EQUIVALENTS - END OF PERIOD$171,372  $219,513   Schedule 4 OPTION CARE HEALTH, INC.QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES(IN THOUSANDS)(UNAUDITED)  Three Months Ended March 31,  2025   2024 Net income$46,742  $44,791 Interest expense, net 13,231   13,202 Income tax expense 16,814   12,164 Depreciation and amortization expense 16,373   15,305 EBITDA 93,160   85,462     EBITDA adjustments   Stock-based incentive compensation expense 8,801   9,605 Restructuring, acquisition, integration and other 9,806   3,223 Adjusted EBITDA$111,767  $98,290     Net income$46,742  $44,791 Intangible asset amortization expense 9,097   8,609 Stock-based incentive compensation expense 8,801   9,605 Restructuring, acquisition, integration and other 9,806   3,223 Total pre-tax adjustments 27,704   21,437 Tax adjustments (1) (7,342)  (4,588)Adjusted net income$67,104  $61,640     Earnings per share, diluted$0.28  $0.26 Adjusted earnings per share, diluted$0.40  $0.35 Weighted average common shares outstanding, diluted 166,804   175,624   (1) Tax adjustments for the three months ended March 31, 2025 and 2024 includes the estimated income tax effect on non-GAAP adjustments based on the effective tax rate

Related News